HEIDELBERG PHARMA AG
Heidelberg Pharma GmbH, a drug development company, provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. It offers services, such as explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology in the fields of oncology or inflammatory/autoimmune diseases.
HEIDELBERG PHARMA AG
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1999-01-01
Address:
Ladenburg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.heidelberg-pharma.com
Total Employee:
51+
Status:
Active
Contact:
49 6203 10 09 13
Email Addresses:
[email protected]
Total Funding:
200.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Domain Not Resolving Apache Mobile Non Scaleable Content IPv6 Cloudflare JS DigiCert SSL Encryption Everywhere
Similar Organizations
4D Pharma
4D Pharma PLC is a world leader in the development of live biotherapeutics.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Solid Form Solutions
Solid Form Solutions, a provider of solid state chemistry and crystallization development services
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Huadong Medicine
Huadong Medicine investment in Post-IPO Equity - Heidelberg Pharma AG
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding investment in Post-IPO Equity - Heidelberg Pharma AG
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding investment in Post-IPO Equity - Heidelberg Pharma AG
Official Site Inspections
http://www.heidelberg-pharma.com
- Host name: 217-160-0-243.elastic-ssl.ui-r.com
- IP address: 217.160.0.243
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Heidelberg Pharma AG"
Company Overview - Heidelberg Pharma AG
Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and …See details»
Heidelberg Pharma - Crunchbase Company Profile
Heidelberg Pharma may be growing as indicated by the reduction in its loss per share from €0.14 in the first quarter of 2023 to €0.10 in the same period in 2024, suggesting an improvement in its financial performance. Additionally, the …See details»
Heidelberg Pharma – Wikipedia
Heidelberg Pharma arbeitet an einem Behandlungsansatz in der Onkologie, wobei es den Wirkstoff Amanitin aus dem Knollenblätterpilz für Krebstherapien einsetzt, indem es sogenannte Antikörper-Amanitin-Konjugate herstellt und klinisch entwickelt. Antikörper-Amanitin-Konjugate gehören zu den Antikörper-Wirkstoff-Konjugaten (Antibody Drug Conjugates – ADCs), die die hohe Affinität und Spezifität von Antikörpern mit der Wirksamkeit von kleinen toxischen Molekülen für …See details»
Heidelberg Pharma Research GmbH - The Org
Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company listed on the Frankfurt Stock Exchange in the Regulated Market / Prime Standard. Heidelberg Pharma …See details»
Managementteam – Heidelberg Pharma AG
Prof. Dr. Andreas Pahl ist seit Februar 2024 Sprecher des Vorstands der Heidelberg Pharma AG und Geschäftsführer der Tochtergesellschaft Heidelberg Pharma Research GmbH. Davor war er seit 2016 Vorstand für Forschung und …See details»
Heidelberg Pharma AG | LinkedIn
Heidelberg Pharma AG | 5.217 Follower:innen auf LinkedIn. Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the …See details»
Heidelberg Pharma - Funding, Financials, Valuation & Investors
Heidelberg Pharma is registered under the ticker ETR:HPHA . Stock Symbol ETR:HPHA ; IPO Date Nov 17, 2006; Stock chart by . Investors. Edit Investors Section. Number of Lead …See details»
Heidelberg Pharma AG Company Description - Stock Analysis
Jan 9, 2025 Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the …See details»
Heidelberg Pharma - PitchBook
Heidelberg Pharma General Information Description. Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted …See details»
PR: Heidelberg Pharma announces financial figures and reports on ...
Mar 25, 2024 Heidelberg Pharma receives patent for the use of the Amanitin-based ADC technology platform: In November 2023, the subsidiary Heidelberg Pharma Research GmbH …See details»
Heidelberg Pharma AG, HPHX.A:GER profile - FT.com
Jan 10, 2025 Year on year Heidelberg Pharma AG 's revenues fell -46.75%from 18.51m to 9.86m. In addition, the company has been unable to reduce the cost of goods sold, selling, …See details»
Heidelberg Pharma Company Profile - Office Locations ... - Craft
Oct 21, 2020 Heidelberg Pharma has 5 employees across 2 locations and €9.86 m in annual revenue in FY 2023. See insights on Heidelberg Pharma including office locations, …See details»
Heidelberg Pharma - Overview, News & Similar companies
Mar 4, 2024 Who is Heidelberg Pharma. Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other …See details»
Heidelberg Pharma AG | European Clinical Trials Information …
Heidelberg Pharma AG is a German biopharmaceutical company that specializes in the development of innovative therapeutic. Menu. Search for Clinical Trials. Autoimmunity. …See details»
Share Price, Shareholder Structure, Basic Information - Heidelberg …
Heidelberg Pharma AG ist ein Biotechnologie-Unternehmen, das Antikörper-Wirkstoff-Konjugate für die Krebstherapie entwickelt. Share, Shareholder Structure, Basic Information - Heidelberg …See details»
华东医药收购德国Heidelberg 交易审批落定，持续深耕ADC全球研 …
⌈ByDrug医药新闻摘要⌋ 2022-08-16 19:56，触界生物：按照股权收购协议，接下来华东医药将启动认购Heidelberg Pharma公开增发股票及协议转让股份的程序。 收购德国ADC明星药企 前沿 …See details»
Heidelberg Pharma AG (Heidelberg Pharma AG) - 药物管线_专利_ …
了解Heidelberg Pharma AG (Heidelberg Pharma AG)公司的药物管线，治疗领域，技术平台，以及它的15项临床试验, 72篇新闻和20篇文献，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统 …See details»
ANNUAL REPORT 2020 - Heidelberg Pharma
Financial position of Heidelberg Pharma Based on its most recent guidance updated in September 2020, Heidelberg Pharma achieved its financial tar-gets. Sales revenue was up …See details»
Transforming Medicine: Cutting-Edge Applications of Nanoscale …
7 hours ago Since their inception in the early 1960s, the development and use of nanoscale materials have progressed tremendously, and their roles in diverse fields ranging from human …See details»
Portfolio overview - Heidelberg Pharma AG
Heidelberg Pharma AG ist ein Biotechnologie-Unternehmen, das Antikörper-Wirkstoff-Konjugate für die Krebstherapie entwickelt.See details»